The FDA has approved a quadrivalent formulation of Flublok® influenza vaccine. Flublok Quadrivalent contains the three strains found in trivalent Flublok plus an additional B strain.

Compared to other quadrivalent influenza vaccines, Flublok Quadrivalent contains three times more active ingredient, making it the first high antigen quadrivalent vaccine approved by the FDA.